Prevalencia de inmunidad frente a los virus de la hepatitis en gestantes del Área Sanitaria de Gijón

González, Adolfo Suárez; Sánchez, Gonzalo Solís; Guerra, Lenin Cavalcanti Brito; Guerra, Guillermo Viejo de la; Navascués, C.A.; López, R. García

doi:10.1016/s0210-5705(03)70473-7

Cited by 7 publications

(1 citation statement)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In Spain, IgG seroprevalence among pregnant women varies from 0.6 to 5.4%, similar to the prevalence in general population [252–254]. IgM seroprevalence reported was 0.67% [254], suggesting that although subclinical infections exist, prevalence is very low.…”

Section: Routes Of Transmission and Risk Groupssupporting

confidence: 53%

Hepatitis E Virus in Industrialized Countries: The Silent Threat

Clemente-Casares

Ramos-Romero

Ramirez-Gonzalez

et al. 2016

BioMed Research International

View full text Add to dashboard Cite

Hepatitis E virus (HEV) is the main cause of acute viral hepatitis worldwide. Its presence in developing countries has been documented for decades. Developed countries were supposed to be virus-free and initially only imported cases were detected in those areas. However, sporadic and autochthonous cases of HEV infection have been identified and studies reveal that the virus is worldwide spread. Chronic hepatitis and multiple extrahepatic manifestations have also been associated with HEV. We review the data from European countries, where human, animal, and environmental data have been collected since the 90s. In Europe, autochthonous HEV strains were first detected in the late 90s and early 2000s. Since then, serological data have shown that the virus infects quite frequently the European population and that some species, such as pigs, wild boars, and deer, are reservoirs. HEV strains can be isolated from environmental samples and reach the food chain, as shown by the detection of the virus in mussels and in contaminated pork products as sausages or meat. All these data highlight the need of studies directed to control the sources of HEV to protect immunocompromised individuals that seem the weakest link of the HEV epidemiology in industrialized regions.

show abstract

Section: Routes Of Transmission and Risk Groupssupporting

confidence: 53%